Genomic Instability. Kent Nastiuk, PhD Dept. Cancer Genetics Roswell Park Cancer Institute. RPN-530 Oncology for Scientist-I October 18, 2016

Similar documents
Genomic instability. Amin Mahpour

Development of Carcinoma Pathways

Computer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015

Molecular mechanisms of human carcinogenesis

American Society of Cytopathology Core Curriculum in Molecular Biology

An adult human has somewhere around one hundred trillion (10 14 ) cells

Chromothripsis: A New Mechanism For Tumorigenesis? i Fellow s Conference Cheryl Carlson 6/10/2011

609G: Concepts of Cancer Genetics and Treatments (3 credits)

The mutations that drive cancer. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge

Chapt 15: Molecular Genetics of Cell Cycle and Cancer

Introduction to Cancer Biology

Characterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser

Mohammed El-Khateeb. Tumor Genetics. MGL-12 May 13 th Chapter 22 slide 1 台大農藝系遺傳學

Defining chromosomal instability

Cancer and sornat ic evolution

Prof. R. V. Skibbens

Mohammed El-Khateeb. Tumor Genetics. MGL-12 July 21 st 2013 台大農藝系遺傳學 Chapter 22 slide 1

Colon Cancer and Hereditary Cancer Syndromes

Chromosomes with two centromeres and the breakage-fusion-bridge cycle

CELL CYCLE REGULATION AND CANCER. Cellular Reproduction II

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

Structural Variation and Medical Genomics

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014

Genetic Testing Methods

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

Biology of cancer development in the GI tract

Session 4 Rebecca Poulos

oncogenes-and- tumour-suppressor-genes)

Precision Genetic Testing in Cancer Treatment and Prognosis

CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)

LESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2

Tumor suppressor genes D R. S H O S S E I N I - A S L

Multistep nature of cancer development. Cancer genes

Karyotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl

Neoplasia 18 lecture 6. Dr Heyam Awad MD, FRCPath

Session 4 Rebecca Poulos

Cancer Cells. It would take another 20 years and a revolution in the techniques of biological research to answer these questions.

UNC-Duke Biology Course for Residents Fall Cell Cycle Effects of Radiation

CNV Detection and Interpretation in Genomic Data

Cell Division. non-mitotic cell. Dividing (mitotic) cell. (This movie has been sped up.) These chromosomes have been marked with RED fluorescence.

A. Incorrect! All the cells have the same set of genes. (D)Because different types of cells have different types of transcriptional factors.

Clonal evolution of human cancers

MOLECULAR BASIS OF ONCOGENESIS

Lecture 1: Carcinogenesis

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous

Asingle inherited mutant gene may be enough to

Lynch Syndrome. Angie Strang, PGY2

HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007

Cytogenetics Technologies, Companies & Markets

CHROMOSOMAL MICROARRAY (CGH+SNP)

Lecture 1: Carcinogenesis

Cancer Genomes How to Analyze Your Own Genome

Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns

Section D: The Molecular Biology of Cancer

New: P077 BRCA2. This new probemix can be used to confirm results obtained with P045 BRCA2 probemix.

Approach to Mental Retardation and Developmental Delay. SR Ghaffari MSc MD PhD

Chen-Yang Shen, 1 Jyh-Cherng Yu, Yen-Li Lo, Chia-Hui Kuo, Chung-Tai Yue, Yuh-Shan Jou, Chiun-Sheng Huang, Jia-Chyi Lung, and Cheng-Wen Wu

Cancer genetics

What s the Human Genome Project Got to Do with Developmental Disabilities?

Breast Cancer Statistics

An Overview of Cytogenetics. Bridget Herschap, M.D. 9/23/2013

Cancer. Questions about cancer. What is cancer? What causes unregulated cell growth? What regulates cell growth? What causes DNA damage?

Application of Whole Genome Microarrays in Cancer: You should be doing this test!!

Anatomic Molecular Pathology: An Emerging Field

Repair of Broken Chromosomes and Maintenance of Chromosome Stability

Brian T Burgess, DO, PhD, GYN Oncology Fellow Rachel W. Miller, MD, GYN Oncology

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Overview of the core ideas in cancer research

Genetics of Oncology. Ryan Allen Roy MD July 8, 2004 University of Tennessee

Introduction to Genetics

The Cancer Genome Atlas & International Cancer Genome Consortium

Chapter 9. Cells Grow and Reproduce

TumorNext-Lynch. genetic testing for hereditary colorectal or uterine cancer

BIO360 Quiz #1. September 14, Name five of the six Hallmarks of Cancer (not emerging hallmarks or enabling characteristics ): (5 points)

contact info. Course coordinator can be reached at

Personalized Genetics

Sharan Goobie, MD, MSc, FRCPC

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar

Present State of Gene Diagnosis and Future Prospects

Regulators of Cell Cycle Progression

What is New in Genetic Testing. Steven D. Shapiro MS, DMD, MD

Hands-On Ten The BRCA1 Gene and Protein

Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University

BASIC CONCEPTS OF CANCER: GENOMIC DETERMINATION

Profiles of gene expression & diagnosis/prognosis of cancer. MCs in Advanced Genetics Ainoa Planas Riverola

Human Genetics 542 Winter 2018 Syllabus

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar

Genomic Medicine: What every pathologist needs to know

The Role of ploidy in neuroblastoma. Michael D. Hogarty, MD Division of Oncology Children s Hospital of Philadelphia

Human Genetics 542 Winter 2017 Syllabus

A class of genes that normally suppress cell proliferation. p53 and Rb..ect. suppressor gene products can release cells. hyperproliferation.

The Hallmarks of Cancer

Chromosomal instability (CIN): what it is and why it is crucial to cancer evolution

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.

Prof. R. V. Skibbens. BIOS 10 and BIOS 90: BioScience in the 21 st Century. Cell Cycle, Cell Division and intro to Cancer.

Significance of Chromosome Changes in Hematological Disorders and Solid Tumors

Transformation of Normal HMECs (Human Mammary Epithelial Cells) into Metastatic Breast Cancer Cells: Introduction - The Broad Picture:

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

Genomic analysis of childhood High grade glial (HGG) brain tumors

Transcription:

Genomic Instability Kent Nastiuk, PhD Dept. Cancer Genetics Roswell Park Cancer Institute RPN-530 Oncology for Scientist-I October 18, 2016 Previous lecturers supplying slides/notes/inspiration Daniel L. Stoler, Ph.D. Bill Burhans, Ph.D. Amin Mahpour, (almost Ph.D.?) Genomic Instability RPN-530 Oncology for Scientist-I 2 1

Questions/Outline What is Genomic instability? What factors contribute to genome integrity? How we identify these aberrations? Notta, et al, Nature October 12, 2016 doi:10.1038/nature19823 Genomic Instability RPN-530 Oncology for Scientist-I 3 Genomic instability Cells maintain genome integrity and promote faithful genome propagation by: o o o Coordinated DNA replication DNA-damage sensing and repair Cell-cycle checkpoints Most checkpoints evolutionarily conserved and are tumor suppressors Genomic Instability RPN-530 Oncology for Scientist-I 4 2

Genomic instability Drives evolution at the molecular level and generates genetic variation/diversity Specialized role in generation of variability in developmentally regulated processes o Immunoglobulin diversification Associated with pathological disorders o Premature aging o Inherited disease o Cancer Genomic Instability RPN-530 Oncology for Scientist-I 5 Cancer Evolution at a vastly accelerated rate with natural selection favoring the growing tumor mass over the organism. Successive gene mutations activating oncogenes and inactivating tumor suppressors. Genomic Instability RPN-530 Oncology for Scientist-I 6 3

Genomic Instability RPN-530 Oncology for Scientist-I 7 Early Molecular Model of Tumor Progression - Vogelstein Hypothesis: Mutation in one gene associated with each step in progression. Fearon & Vogelstein, Cell 61, 759 767 ( 1990). Genomic Instability RPN-530 Oncology for Scientist-I 8 4

Early Molecular Model of Tumor Progression- Vogelstein Problem 1: Vogelstein pathway is no more than a rough outline Genomic Instability RPN-530 Oncology for Scientist-I 9 Early Molecular Model of Tumor Progression Problem 2: How do you accumulate all of these mutations in one cell? Molecular pathogenesis of colorectal cancer Cancer Volume 104, Issue 10, pages 2035-2047, 4 OCT 2005 DOI: 10.1002/cncr.21462 Genomic Instability RPN-530 Oncology for Scientist-I 10 5

Genomic Instability RPN-530 Oncology for Scientist-I 11 Cancer is a genetic disease Genetic selection at the level of single cells. Aneuploidy is a hallmark of cancer cells. Somatic mutations occur in most cancers. Inherited germline mutations occur in rare familial cancer syndromes. Increases in mutation rate or genomic instability increase frequency of cancer. Genomic Instability RPN-530 Oncology for Scientist-I 12 6

Genomic Instability in cancer Genomic instability is a fundamentally important feature of (all) cancer cells. o Chromosomal instability o Intrachromosomal instability CIN o Microsatellite instability à MSI o Epigenetic instability (Is instability a cause or consequence of cancer?) Genomic Instability RPN-530 Oncology for Scientist-I 13 Genomic Instability in cancer 1990: Tlsty. Tumor cells growing in culture are genomically unstable; elevated gene amplification rates. Genomic instability is a continuous process since it was inherited by daughter tumor cells. 1991: Loeb. Normal rate of mutation (1.4 x 10-10 nucleotides/ cell division) was insufficient to produce the estimated necessary mutations to achieve cancer. Need for Mutator Phenotype. 1992: Kallioniemi and Pinkel. Comparative genomic hybridization showed amplifications and deletions in cancer, more than existing dogma. 1993: Fishel and Kolodner. Hereditary nonpolyposis colorectal cancer arises from defects in DNA mismatch repair. Microsatellite instability. Genomic Instability RPN-530 Oncology for Scientist-I 14 7

Familial Cancer Syndromes Hereditary Nonpolyposis Colorectal Cancer o Mismatch Repair Genes Familial Breast/Ovarian Cancer o BRCA1/2 Ataxia Telangiectasia o ATM Li- Fraumeni Syndrome o p53 Werner s and Bloom s Syndromes o DNA Helicases Mutator Hypothesis Genomic Instability RPN-530 Oncology for Scientist-I 15 Forms of instability Chromosomal Instability(CIN) o o o Microscopic changes in the Karyotype Chromosomal gain or loss (Aneuploidy) Chromosomal translocation Failures in either mitotic chromosome transmission or the spindle mitotic checkpoint Can be studied by Cytogenetics techniques Microsatellite Instability(MSI or MIN) o o Repetitive DNA expansions and contractions. Replication slippage Mismatch repair (MMR) impairment Homologous recombination Require molecular techniques(i.e. PCR) to identify them Mutations, small deletions, insertions, inversions, etc. o Identify by sequencing Epigenetic instability o Identify by ChIP-seq, WGBS, etc Genomic Instability RPN-530 Oncology for Scientist-I 16 8

Questions/Outline What is Genomic instability? What factors contribute to genome integrity? How we identify these aberrations? Notta, et al, Nature October 12, 2016 doi:10.1038/nature19823 Genomic Instability RPN-530 Oncology for Scientist-I 17 Chromosomal Instability Spindle Assembly Checkpoint Centrosome number and geometry Genomic Instability RPN-530 Oncology for Scientist-I 718 9

Genomic Instability RPN-530 Oncology for Scientist-I 19 Genomic Instability RPN-530 Oncology for Scientist-I 20 10

Microsatellite instability Replication slippage CACACA CACACA CACACACACACACACA CACACACACACACACA Mismatch repair failure Genomic Instability RPN-530 Oncology for Scientist-I 821 Genomic Instability RPN-530 Oncology for Scientist-I 22 11

Telomere attrition contribute to genomic instability DNA replication Telomeres Telomerase p53 ALT Telomerase OE Crisis Apoptosis End to end fusion Anaphase breakage End to end fusion Genomic Instability RPN-530 Oncology for Scientist-I 223 Oncogenes promote DNA replication Oncogenic signal Replicons S phase Replicons Genomic Instability RPN-530 Oncology for Scientist-I 1924 12

Oncogenes and local replication/ Amplifications Growth and survival advantage (e.g. Myc) Genomic Instability RPN-530 Oncology for Scientist-I 2025 Copy number increase of replication factors in cancer Current Biology 2014 24, R435-R444DOI: (10.1016/j.cub.2014.04.012) Genomic Instability RPN-530 Oncology for Scientist-I 26 13

Oncogene activation causes replicative stress and genomic instability. Current Biology 2014 24, R435-R444DOI: (10.1016/j.cub.2014.04.012) Genomic Instability RPN-530 Oncology for Scientist-I 27 DNA damage checkpoint Double strand break Alkylated nucleotide Replication stress p53 ATM CHK2 ATR CHK1 BRCA1 apoptosis repair Cell cycle arrest Genomic Instability RPN-530 Oncology for Scientist-I 1328 14

10/18/16 Replication stress induced DNA damage Causes and consequences of replication stress Michelle K. Zeman & Karlene A. Cimprich Nature Cell Biology 16, 2 9 (2014) doi:10.1038/ncb2897 Genomic Instability RPN-530 Oncology for Scientist-I 29 Chromothripsis Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development, Stephens et al, Cell 2011 Genomic Instability RPN-530 Oncology for Scientist-I 30 15

Chromothripsis Genomic Instability RPN-530 Oncology for Scientist-I 31 Questions/Outline What is Genomic instability? What factors contribute to genome integrity? How we identify these aberrations? Notta, et al, Nature October 12, 2016 doi:10.1038/nature19823 Genomic Instability RPN-530 Oncology for Scientist-I 32 16

Part III: Measurements of Genomic Instabilities Inter-Sample Sequence, Repeat PCR Allelotyping (SNP arrays) Comparative Genomic Hybridization o BAC-Array Spectral Karyotyping Karyotyping Size of DNA damage detected increases. Genomic Instability RPN-530 Oncology for Scientist-I 33 IDENTIFICATION OF GENOMIC INSTABILITY Cytogenetic - Karyotyping Genomic Instability RPN-530 Oncology for Scientist-I 2534 17

Spectral Karyotyping (SKY) Photo: Autism Spectrum Disorder in a Girl with a De Novo X;19 Balanced Translocation. Hindawi 2012 Genomic Instability RPN-530 Oncology for Scientist-I 2735 Changes produce genomic and karyotypic instability and often show gross rearrangements Normal cells Cancerous cells Genomic Instability RPN-530 Oncology for Scientist-I 36 18

Fluorescent In Situ Hybridization(FISH) Fluorescent In Situ Hybridization(FISH) PNA Probe fluorophore Photo: Swiss perinatal institute Genomic Instability RPN-530 Oncology for Scientist-I 2637 Microarray Comparative Genomic Hybridization(M-CGH) Photo: Agilent Genomic Instability RPN-530 Oncology for Scientist-I 2838 19

Utilization of CGH in cancer High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood. 2009 29 Genomic Instability RPN-530 Oncology for Scientist-I 39 Virtual Karyotype Genomic Instability RPN-530 Oncology for Scientist-I 40 20

Next-generation sequencing(ngs) Best way to analyze genomic instability is to sequence the cancer genome. Exome sequencing has been used to analyzed Lung, glioblastoma and many other cancers. The data is publicly available through TCGA and other sequencing consortium. Whole genome sequencing is expensive, but provides more details about cancer genome(e.g. Noncoding and promoter sequence). Genomic Instability RPN-530 Oncology for Scientist-I 41 Characterizing MSI CA repeats Genomic Instability RPN-530 Oncology for Scientist-I 42 21

Changes that produce genomic and karyotypic instability Defects in DNA replication machinery lost capability to reproduce genome faithfully Increase rate of chromosomal aberrations fidelity of chromosome reproduction greatly diminished Genomic Instability RPN-530 Oncology for Scientist-I 43 Quantifying Genomic Alterations by Direct DNA Sequencing - 2006 Sequenced 13,023 genes in each of 11 breast carcinomas and in each of 11 colon carcinomas. o 189 genes had above average mutation frequencies. o The average tumor had 93 genes mutated. o This set varied from tumor to tumor. o In addition to point mutations, many indels of 1-100 bases. Sjoblom et al, Science 314:268-274, 2006. Kaiser, Science 313:1370, 2006 Genomic Instability RPN-530 Oncology for Scientist-I 44 22

Quantifying Genomic Alterations by Direct DNA Sequencing This pattern of diversity applies to most solid tumors o Breast, Gastric, Lung Ovarian Renal Colorectal o Head and Neck Mesothelioma Pancreatic o Nature 446: 153, 2007 o PNAS 105:3521, 2008 Driver Mutations o confer growth advantages on the cancer cell -> positive selection Passenger Mutations o don t confer growth advantages -> no positive selection drivers appear to be distributed across a large number of genes, each of which is mutated infrequently o Stratton et al. Nature 458:719, 2009. Genomic Instability RPN-530 Oncology for Scientist-I 45 When does genomic instability occurduring tumor progression? Early -> driver of progression Late -> result of progression Genomic Instability RPN-530 Oncology for Scientist-I 46 23

Questions/Outline What is Genomic instability? What factors contribute to genome integrity? How we identify these aberrations? Notta, et al, Nature October 12, 2016 doi:10.1038/nature19823 Genomic Instability RPN-530 Oncology for Scientist-I 47 A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns Notta, et al., Nature October 12, 2016 High genomic instability in PancCa Sequence 100 whole genomes Purified primary and metastatic pancreatic ductal Ca Genomic Instability RPN-530 Oncology for Scientist-I 48 24

Polyploidization in pancreatic cancer 45% of tumors Genomic Instability RPN-530 Oncology for Scientist-I 49 Mutations occur prior to polyploidy CNVs occur postpolyploidy Genomic Instability RPN-530 Oncology for Scientist-I 50 25

More copy number alterations post polyploidy Genomic Instability RPN-530 Oncology for Scientist-I 51 Most copy number changes from single chromothripsis event Genomic Instability RPN-530 Oncology for Scientist-I 52 26

10/18/16 Chromothripsis and polyploidization in a patient with metastatic progression Genomic Instability RPN-530 Oncology for Scientist-I 53 All mets polyploid and have myc amplification Genomic Instability RPN-530 Oncology for Scientist-I 54 27

A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns Mets all same ploidy Mets all same chromothripsis event CNVs mostly clonal, so likely late event Genomic Instability RPN-530 Oncology for Scientist-I 55 Examine 96 single cells from one patient Single event knocked out CDKN2A and SMAD4 16% of all PancCa, all 4 drivers altered simultaneously Genomic Instability RPN-530 Oncology for Scientist-I 56 28

Sequential hit model a la Vogelstein Genomic Instability RPN-530 Oncology for Scientist-I 57 Back to problem 1: Vogelstein pathway is no more than a rough outline Genomic Instability RPN-530 Oncology for Scientist-I 58 29

Early Molecular Model of Tumor Progression Problem 2: How do you accumulate all of these mutations in one cell? Genomic Instability RPN-530 Oncology for Scientist-I 59 Complex genomic rearrangement of cancer driver genes LOH after duoploidy Genomic Instability RPN-530 Oncology for Scientist-I 60 30

10/18/16 3 copy number drops are evidence of BFB Genomic Instability RPN-530 Oncology for Scientist-I 61 Simultaneous knockout of pancreatic cancer driver genes Genomic Instability RPN-530 Oncology for Scientist-I 62 31

Which model of tumor progression does the data support? Genomic Instability RPN-530 Oncology for Scientist-I 63 Questions/Outline What is Genomic instability? What factors contribute to genome integrity? How we identify these aberrations? Notta, et al, Nature October 12, 2016 doi:10.1038/nature19823 Genomic Instability RPN-530 Oncology for Scientist-I 64 32